To read the JAMA Viewpoint "Evidence-based clinical prevention in the era of the Patient Protection and Affordable Care Act: the role of the U.S. Preventive Services Task Force," click here.
- Final Recommendation Statement: Screening for Celiac Disease 3/28/2017
- Public Comment on Draft Research Plan: Medication Use for the Risk Reduction of Primary Breast Cancer in Women 3/23/2017
- Public Comment on Draft Research Plan: Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA Related Cancer 3/16/2017
Opportunity for Public Comment
In an effort to make the U.S. Preventive Services Task Force (USPSTF) recommendations clearer and its processes more transparent, the Task Force started posting draft Recommendation Statements online for public comment in 2010. To further enhance its work, the Task Force began inviting public comment on all its draft Research Plans in December 2011 and its draft Evidence Reviews in March 2013.
To learn more about and comment on USPSTF draft Research Plans, Evidence Reviews, or Recommendation Statements, click the links below.
Internet Citation: Home. U.S. Preventive Services Task Force. December 2016.